-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

903.O1.6 903: Health Services and Quality Improvement – Myeloid Malignancies: From Blood to Bombs: Identifying and Addressing Barriers to Care for Myeloid Malignancies

Symposia: Health Services and Quality Improvement –Myeloid Malignancies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Acute Myeloid Malignancies, AML, adult, Clinical Practice (Health Services and Quality), elderly, Clinical Research, health outcomes research, health disparities research, drug development, blood banking, Diseases, Therapies, Adverse Events, Myeloid Malignancies, Technology and Procedures, Study Population, Human
Saturday, December 9, 2023: 2:00 PM-3:30 PM
Hall A (San Diego Convention Center)
Amar H Kelkar, MD, and Rachel J. Cook, MD, Oregon Health and Science University
No relevant conflicts of interest to declare.
2:00 PM

Pamela Egan, MD1,2, Ari Pelcovits, MD1, Caitlyn Krar3*, Stephen Donnelly, BS4*, Lila Rubin, MD5*, Rabin Niroula6*, John L. Reagan, MD7, Dana Guyer, MD8*, Adam J Olszewski, MD9 and Thomas W LeBlanc, MD10

1Lifespan Cancer Institute, Legoretta Cancer Center of Brown University, Providence, RI
2MaineHealth Cancer Care, Portland, ME
3Lifespan Cancer Institute, Providence, RI
4Lifespan Oncology Clinical Research, Rhode Island Hospital, Providence, RI
5Rhode Island Hospital, Providence, RI
6Lifespan Cancer Institute, The Warren Alpert Medical School of Brown University, Providence, RI
7Legorreta Cancer Center of Brown University, Providence, RI
8Brown University/Lifespan Cancer Institute, Providence, RI
9Legorreta Cancer Center at Brown University, Lifespan Cancer Institute, Providence, RI
10Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC

2:15 PM

Marissa Locastro, BS1*, Soroush Mortaz-Hedjri, MD, MS2*, Ying Wang, MS1*, Jason H. Mendler, MD1, Sally Norton, PhD, RN, FNAP, FPCN, FAAN1*, Rachelle Bernacki, MD3*, Thomas Carroll, MD, PhD1*, Heidi Klepin, MD4, Jane L. Liesveld, MD5, Eric J Huselton, MD6*, Benzi Kluger, MD1* and Kah Poh Loh, MD, MS7*

1University of Rochester Medical Center, Rochester, NY
2James P Wilmot Cancer Institute, Rochester
3Harvard Medical School, Boston, MA
4Wake Forest University School of Medicine, Winston Salem, NC
5James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
6James P Wilmot Cancer Center, Rochester, NY
7James P Wilmot Cancer Institute, Rochester, NY

2:30 PM

Christa L Meyer, MS1*, Theresa H.M. Keegan, PhD, MS2, Ann Brunson, MS2*, Jeffery J. Auletta, MD1,3, Lindsay M. Morton, PhD4*, Ted Wun, MD2, Sara J. Schonfeld, PhD4*, Bryan Valcarcel, MD, MPH4, Renata Abrahao, MD, MSc, PhD2*, Rafeek Yusuf, MD, PhD1* and Lori S. Muffly, MD5

1CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
2Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA
3Hematology/Oncology/Bone Marrow Transplant and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH
4Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
5Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA

2:45 PM

Christopher T. Su, MD, MPH1,2, Wael Saber, MD, MS3, Aasthaa Bansal, PhD1*, Li Li, MS1*, Ryotaro Nakamura, MD4, Corey Cutler5, Bart L. Scott, MD1, Lindsey R Sangaralingham, MPH6*, Viengneesee Thao, PhD, MS6*, Joshua Roth, PhD2,7*, Winona Wright, BS1*, Lotte Steuten, PhD8*, Deborah Mattila, BA9* and Scott D Ramsey, MD, PhD1,2*

1Fred Hutchinson Cancer Center, Seattle, WA
2University of Washington, Seattle, WA
3Medical College of Wisconsin, Milwaukee, WI
4Hematologic Malignancies and Stem Cell Transplantation Institute, City of Hope National Comprehensive Cancer Center, Duarte, CA
5Dana-Farber Cancer Institute, Boston, MA
6Mayo Clinic, Robert D. and Patricia E. Kern Center For the Science of Health Care Delivery, Rochester, MN
7Pfizer, New York
8Office of Health Economics, London, GBR
9National Marrow Donor Program/Be The Match, Center for International Blood and Marrow Transplant Research, Minneapolis, MN

3:00 PM

Elizabeth Warner, MBE1*, Thomas P Walsh1*, Daniel J. DeAngelo1, Christopher S. Lathan1*, Gregory A Abel, MD, MPH2 and Andrew Hantel, MD1

1Dana-Farber Cancer Institute, Boston, MA
2DFCI, Boston, MA

3:15 PM

Sergiy Klymenko1*, Irina Korenkova2*, Oleksandr Lysytsia3*, Menachem Bitan, MD, PhD4*, Olena Lukianets, MD5*, Jan M. Zaucha6*, Joannis Mytilineos7*, Andreas Hochhaus, MD8, Mats Heyman9, Francois Guilhot, MD10*, Natacha Bolanos11*, Roman Kuts, MD12*, Hildegard T. Greinix, MD13, Isabel sanchez-Ortega14*, Mickey Boon Chai Koh, MD, PhD15*, Bohdan Medvediev16*, Susan Landgraf17*, Rüdiger Hehlmann, MD 18, Mahmoud Aljurf, MD19*, Torsten Haferlach, MD, PhD20, Arnold Ganser21, Anna Maria Sureda Balari, MD, PhD22, Damiano Rondelli, MD23* and Dietger W. Niederwieser, MD24

1Feofaniya Hospital, Kyiv, UKR
2Kyiv Bone Marrow Transplantation Center, 119 Peremohy avenue, Kyiv, kyiv, Ukraine
3National Specialized Children's Hospital "Ohmatdyt", Kyiv, Ukraine
4Meuhedet HMO and The Hebrew University of Jerusalem, Jerusalem, Israel
5Clinical Center of Oncology, Hematology, Transplantology and Palliative Care of Cherkasy Oblast Council,, Cherkasy, Ukraine
6Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland
7Zentrales Knochenmarkspenderregister Deutschlands (ZKRD), Ulm, Germany
8Department Hematology and Oncology, Klinik für Innere Medizin II, Jena, Germany
9Astrid Lindgren Children’s Hospital, Karolinska University Hospital, Stockholm, Sweden
10University of Poitiers, Poitiers, France, FRA
11Lymphoma coalition, Madrid, Spain
12Ukrainian Bone Marrow Donor Registry, Kyiv, Ukraine
13Division of Hematology, Department of Internal Medicine, Medical University of Graz, Graz, Austria
14EBMT executive Office, Barcelona, Spain
15St George's University Hospitals, London, United Kingdom
16Kyiv Bone Marrow Transplantation Center, Kyiv, Ukraine
17St. Georg Hospital, Leipzig, Germany
18ELN-Foundation, Weinheim, Germany
19King Faisal Specialist Hospital & Research Centre, Oncology (Section of Adult Haematolgy/BMT) – Riyadh, Saudi Arabia, Riyadh, Saudi Arabia
20MLL Munich Leukemia Laboratory, Munich, Germany
21Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
22Clinical Hematology Department, Institut Català d’Oncologia, Hospital Duran i Reynals, IDIBELL, Univerisitat de Barcelona, Barceloma, Spain
23Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
24University of Leipzig, Leipzig, Germany

*signifies non-member of ASH